This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Oct;260(7):561-2.

doi: 10.1007/s00406-010-0105-2. Epub 2010 Feb 14.

Is the word 'biomarker' being properly used by proteomics research in neuroscience?

Daniel Martins-de-Souza

PMID: 20155362
PMCID: PMC2953633
DOI: 10.1007/s00406-010-0105-2

Is the word 'biomarker' being properly used by proteomics research in neuroscience?

Daniel Martins-de-Souza. Eur Arch Psychiatry Clin Neurosci. 2010 Oct.

. 2010 Oct;260(7):561-2.

doi: 10.1007/s00406-010-0105-2. Epub 2010 Feb 14.

Author

Daniel Martins-de-Souza

PMID: 20155362
PMCID: PMC2953633
DOI: 10.1007/s00406-010-0105-2

No abstract available

PubMed Disclaimer

Figures

Fig. 1 — Fig. 1
a "Biomarker" b "Proteomic or proteomics or proteome and biomarker" on PubMed

See this image and copyright information in PMC

Similar articles

Osteoarthritis year 2012 in review: biomarkers.
Mobasheri A. Mobasheri A. Osteoarthritis Cartilage. 2012 Dec;20(12):1451-64. doi: 10.1016/j.joca.2012.07.009. Epub 2012 Jul 25. Osteoarthritis Cartilage. 2012. PMID: 22842200 Review.
Financial anatomy of neuroscience research.
Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H 3rd. Dorsey ER, et al. Ann Neurol. 2006 Dec;60(6):652-9. doi: 10.1002/ana.21047. Ann Neurol. 2006. PMID: 17192926 Review.
Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
Al Shweiki MR, Oeckl P, Steinacker P, Hengerer B, Schönfeldt-Lecuona C, Otto M. Al Shweiki MR, et al. Expert Rev Proteomics. 2017 Jun;14(6):499-514. doi: 10.1080/14789450.2017.1336435. Expert Rev Proteomics. 2017. PMID: 28562112 Review.
Editorial: QSAR/QSPR models as enabling technologies for drug & targets discovery in: medicinal chemistry, microbiology-parasitology, neurosciences, bioinformatics, proteomics and other biomedical sciences.
Gonzalez-Diaz H. Gonzalez-Diaz H. Curr Top Med Chem. 2012;12(8):799-801. doi: 10.2174/156802612800166738. Curr Top Med Chem. 2012. PMID: 22352908 No abstract available.
Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications.
Möller HJ, Schmitt A, Falkai P. Möller HJ, et al. Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):385-6. doi: 10.1007/s00406-016-0699-0. Eur Arch Psychiatry Clin Neurosci. 2016. PMID: 27216433 No abstract available.

See all similar articles

Cited by

Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?
Vasic N, Connemann BJ, Wolf RC, Tumani H, Brettschneider J. Vasic N, et al. Eur Arch Psychiatry Clin Neurosci. 2012 Aug;262(5):375-91. doi: 10.1007/s00406-011-0280-9. Epub 2011 Dec 16. Eur Arch Psychiatry Clin Neurosci. 2012. PMID: 22173848 Review.
Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy.
Falkai P, Möller HJ. Falkai P, et al. Eur Arch Psychiatry Clin Neurosci. 2010 Oct;260(7):507-8. doi: 10.1007/s00406-010-0154-6. Eur Arch Psychiatry Clin Neurosci. 2010. PMID: 20922543 Free PMC article. No abstract available.
Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers.
Alexopoulos P, Guo LH, Kratzer M, Westerteicher C, Kurz A, Perneczky R. Alexopoulos P, et al. Dement Geriatr Cogn Disord. 2011;32(3):164-70. doi: 10.1159/000332017. Epub 2011 Oct 13. Dement Geriatr Cogn Disord. 2011. PMID: 21997402 Free PMC article.
Biomarkers for psychiatric disorders: where are we standing?
Martins-de-Souza D. Martins-de-Souza D. Dis Markers. 2013;35(1):1-2. doi: 10.1155/2013/321071. Epub 2013 Jul 21. Dis Markers. 2013. PMID: 24167343 Free PMC article. No abstract available.
The potential of biomarkers in psychiatry: focus on proteomics.
Sokolowska I, Ngounou Wetie AG, Wormwood K, Thome J, Darie CC, Woods AG. Sokolowska I, et al. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S9-18. doi: 10.1007/s00702-013-1134-6. Epub 2013 Dec 20. J Neural Transm (Vienna). 2015. PMID: 24357051 Review.

See all "Cited by" articles

References

1. Chakravarty A (2003) Surrogate markers: their role in regulatory decision process. Food and Drug Administration, http://www.fda.gov/cder/Offices/Biostatistics/Chakravarty_376/sld016.htm
1. Mischak H, Apweiler R, Banks RE, et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl. 2007;1:148–156. doi: 10.1002/prca.200600771. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources